Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prevention of deep vein thrombosis in medical patients by low-dose heparin.

Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR.

Scott Med J. 1981 Apr;26(2):115-7.

PMID:
7291971
2.
6.
7.

Effect of low-dose heparin on incidence of postoperative thrombosis in orthopaedic patients.

Abraham-Inpijn L, Vreeken J.

Arch Chir Neerl. 1975;27(1):63-8.

PMID:
1098580
8.

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.

Dahan R, Houlbert D, Caulin C, Cuzin E, Viltart C, Woler M, Segrestaa JM.

Haemostasis. 1986;16(2):159-64.

PMID:
3710294
9.

[Prophylaxis of postoperative deep vein thromboses by means of weak doses of subcutaneous heparin (author's transl)].

Kraytman M, Kutnowski M, Ansay J, Fastrez R.

Acta Chir Belg. 1976 Sep;75(5):519-29. French.

PMID:
1015181
10.

Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.

Eriksson BI, Kälebo P, Anthymyr BA, Wadenvik H, Tengborn L, Risberg B.

J Bone Joint Surg Am. 1991 Apr;73(4):484-93.

PMID:
2013587
11.

Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.

Sasahara AA, Koppenhagen K, Häring R, Welzel D, Wolf H.

Br J Surg. 1986 Sep;73(9):697-700.

PMID:
3530367
12.

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.

Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, Candardjis G.

N Engl J Med. 1983 Oct 20;309(16):954-8.

PMID:
6621623
13.

A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.

Dumas R, Woitinas F, Kutnowski M, Nikolic I, Berberich R, Abedinpour F, Zoeckler S, Gregoire F, Jerkovic M, Egberts JF, et al.

Age Ageing. 1994 Nov;23(6):512-6.

PMID:
9231947
14.

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.

J Bone Joint Surg Am. 1994 Jan;76(1):3-14. Erratum in: J Bone Joint Surg Am 1994 Mar;76(3):4741.

PMID:
8288662
15.

Low dose heparin in the prevention of deep-vein thrombosis after aortic bifurcation graft surgery.

Belch JJ, Lowe GD, Pollock JG, Forbes CD, Prentice CR.

Thromb Haemost. 1980 Feb 29;42(5):1429-33.

PMID:
7368149
16.

Prevention of venous thrombosis with small, subcutaneous doses of heparin.

Gallus AS, Hirsh J, O'Brien SE, McBride JA, Tuttle RJ, Gent M.

JAMA. 1976 May 3;235(18):1980-2.

PMID:
946507
17.

[The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)].

Hubens A, Peeters R.

Acta Chir Belg. 1976 Jul;75(4):402-15. Dutch.

PMID:
797205
18.

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke.

McCarthy ST, Turner JJ, Robertson D, Hawkey CJ, Macey DJ.

Lancet. 1977 Oct 15;2(8042):800-1.

PMID:
71605
19.
20.

Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy.

Vandendris M, Kutnowski M, Futeral B, Gianakopoulos X, Kraytman M, Gregoir W.

Urol Res. 1980;8(4):219-21.

PMID:
7013228

Supplemental Content

Support Center